抗抑郁药与初级保健患者新发高血压的关系
该回顾性队列研究利用2008至2015年6224例初级保健患者的电子病历数据,分析抗抑郁药使用与新发高血压的关联。未调整模型中,可能升高血压的抗抑郁药与新发高血压显著相关(HR 1.30,95%CI 1.08-1.57),但调整协变量后关联不再显著(HR 1.20,95%CI 0.97-1.49)。结论认为控制混杂因素后,常用抗抑郁药与新发高血压无显著关联。
要点
- 未调整时,可能升高血压的抗抑郁药与新发高血压显著相关(HR 1.30)。
- 调整协变量后,该关联不再显著(HR 1.20,95%CI 0.97-1.49)。
- 常用抗抑郁药与新发高血压无显著关联,需研究剂量和疗程效应。
核心结论
- 控制抗抑郁药使用和高血压相关因素后,常用抗抑郁药与新发高血压无显著关联。
研究设计与样本
- 回顾性队列研究,使用2008至2015年6224例初级保健患者的电子病历数据。
- 通过处方订单识别抗抑郁药使用,高血压由病历诊断定义。
- 依据药品说明书警告构建三级暴露变量:可能升高血压的抗抑郁药、不升高血压的抗抑郁药和无抗抑郁药。
- 计算未调整和调整的Cox比例风险模型评估关联。
主要发现
- 未调整结果:与无抗抑郁药组相比,可能升高血压的抗抑郁药使用与新发高血压显著相关(HR 1.30,95%CI 1.08-1.57)。
- 调整协变量后,可能升高血压的抗抑郁药使用与新发高血压关联不再显著(HR 1.20,95%CI 0.97-1.49)。
临床怎么用
- 在初级保健中,常用抗抑郁药处方无需因新发高血压风险而过度担忧。
- 对使用可能升高血压抗抑郁药的患者,仍应结合个体情况监测血压。
局限性
- 需进一步研究抗抑郁药的潜在剂量和疗程效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Many ADMs can alter blood pressure (BP), but the research on the effect of antidepressant medication (ADMs) on incident hypertension is mixed. We investigated whether the use of ADMs was associated with the subsequent development of hypertension. METHODS: A retrospective cohort study was conducted using electronic medical record data from 6224 patients with primary care visits from 2008 to 2015. Prescription orders were used to identify ADM use, and hypertension was defined by medical record diagnosis. Using package insert warnings, a 3-level ADM exposure variable was created: ADMs that increase BP (ADM BP+), ADMs that do not increase BP, and no ADM. Unadjusted and adjusted Cox proportional hazard models were computed to estimate the association between the ADM exposure and incident hypertension. RESULTS: Unadjusted results revealed that ADM BP+ use compared with the no ADM group was significantly associated with incident hypertension (hazard ratio, 1.30; 95% confidence interval, 1.08-1.57). After adjusting for covariates, ADM BP+ use was no longer significantly associated with incident hypertension (hazard ratio, 1.20; 95% confidence interval, 0.97-1.49). CONCLUSIONS: Commonly used ADMs were not associated with incident hypertension after controlling for other factors associated with ADM use and hypertension. Research on potential dose and duration effects is warranted.
引用
- Breeden M, Brieler J, Salas J, et al. Antidepressants and Incident Hypertension in Primary Care Patients. J Am Board Fam Med. 2018. PMID: 29330236. doi:10.3122/jabfm.2018.01.170234
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。